Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$17.03 - $22.45 $4.87 Million - $6.43 Million
-286,235 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$19.3 - $26.92 $7.79 Million - $10.9 Million
-403,751 Reduced 58.52%
286,235 $6.55 Million
Q2 2020

Aug 14, 2020

BUY
$22.0 - $22.5 $15.2 Million - $15.5 Million
689,986 New
689,986 $15.5 Million

About Akouos, Inc.


  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.